| JDVVX | RMEBX | JDVVX / RMEBX | |
| Total Expense Ratio | 0.65 | 1.07 | 61% |
| Annual Report Gross Expense Ratio | 0.66 | 1.07 | 62% |
| Fund Existence | 17 years | 11 years | - |
| Gain YTD | 5.925 | 2.231 | 266% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 19.1B | 112B | 17% |
| Annual Yield % from dividends | 0.82 | 1.08 | 75% |
| Returns for 1 year | 12.37 | 7.30 | 169% |
| Returns for 3 years | 24.51 | 28.21 | 87% |
| Returns for 5 years | 26.40 | 43.15 | 61% |
| Returns for 10 years | 81.36 | 103.95 | 78% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AALG | 14.44 | 0.72 | +5.25% |
| Leverage Shares 2X Long Aal Daily ETF | |||
| BNDW | 68.76 | 0.01 | +0.01% |
| Vanguard Total World Bond ETF | |||
| GMAY | 41.51 | -0.14 | -0.34% |
| FT Vest U.S. Eq Mod Buffr ETF - May | |||
| RSEE | 35.56 | -0.24 | -0.66% |
| Rareview Systematic Equity ETF | |||
| THNR | 25.65 | -0.72 | -2.73% |
| Amplify Weight Loss Drug & Treatment ETF | |||